A detailed history of Full Sail Capital, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Full Sail Capital, LLC holds 3,917 shares of ABT stock, worth $501,101. This represents 0.03% of its overall portfolio holdings.

Number of Shares
3,917
Previous 5,535 29.23%
Holding current value
$501,101
Previous $575,000 22.43%
% of portfolio
0.03%
Previous 0.04%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$100.07 - $118.13 $161,913 - $191,134
-1,618 Reduced 29.23%
3,917 $446,000
Q2 2024

Aug 14, 2024

BUY
$100.73 - $112.44 $906 - $1,011
9 Added 0.16%
5,535 $575,000
Q1 2024

May 14, 2024

SELL
$109.52 - $120.96 $16,318 - $18,023
-149 Reduced 2.63%
5,526 $628,000
Q4 2023

Feb 13, 2024

BUY
$90.19 - $110.4 $143,402 - $175,536
1,590 Added 38.92%
5,675 $624,000
Q3 2023

Nov 13, 2023

BUY
$95.53 - $114.62 $34,963 - $41,950
366 Added 9.84%
4,085 $395,000
Q2 2023

Aug 14, 2023

SELL
$100.78 - $112.29 $42,529 - $47,386
-422 Reduced 10.19%
3,719 $405,000
Q1 2023

May 04, 2023

BUY
$96.86 - $114.01 $774 - $912
8 Added 0.19%
4,141 $419,000
Q4 2022

Feb 06, 2023

BUY
$95.06 - $111.52 $177,286 - $207,984
1,865 Added 82.23%
4,133 $453,000
Q3 2022

Nov 09, 2022

BUY
$96.76 - $112.03 $219,451 - $254,084
2,268 New
2,268 $220,000
Q1 2022

May 12, 2022

SELL
$114.02 - $139.04 $223,593 - $272,657
-1,961 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$115.53 - $141.46 $14,441 - $17,682
125 Added 6.81%
1,961 $242,000
Q3 2021

Oct 26, 2021

SELL
$116.66 - $129.06 $4,666 - $5,162
-40 Reduced 2.13%
1,836 $217,000
Q2 2021

Aug 12, 2021

SELL
$105.79 - $124.53 $7,828 - $9,215
-74 Reduced 3.79%
1,876 $217,000
Q4 2020

Feb 11, 2021

BUY
$105.0 - $114.42 $204,750 - $223,119
1,950 New
1,950 $223,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $224B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Full Sail Capital, LLC Portfolio

Follow Full Sail Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Full Sail Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Full Sail Capital, LLC with notifications on news.